Chronic Calculous CholecystitisNCT07339501
Cystic Artery Preservation : an Additional Step for Safe Laparoscopic Cholecystectomy
A study testing The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a and The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery in people with Chronic Calculous Cholecystitis, run by Suez University at 1 site in Egypt.
Trial summary
Our aim is to feature additional steps for safe cholecystectomy by preserving the cystic artery. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Chronic Calculous Cholecystitis
- What is being tested?
- The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a and The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 200 participants
- Where
- 1 siteEgypt
- Study dates
- 12 Aug 2025to 1 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- 1-Patients with symptomatic gall bladder stones. 2-Patients with normal coagulation profile.
Who cannot join
- 1- Patients with hepatic co-morbidity especially (cirrhosis). 2-Patients with previous upper abdominal surgery.
Trial locations and contacts
1 site in 1 country.
About this study
Our aim is to feature additional steps for safe cholecystectomy by preserving the cystic artery.
- Conditions
- Chronic Calculous Cholecystitis
- Being tested
- The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a, The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery aProcedure or surgery
The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery for save cholecystectomy
The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic arteryProcedure or surgery
The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery
| Study group | Role | What they receive |
|---|---|---|
| group (A) | Active comparator | Not described Receives: Procedure: The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a |
| group B | Placebo comparator | Not described Receives: Procedure: The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patients will be followed up by Abdominal ultrasound for post operative abdominal collection
Follow up with ultrasound to evaluate if there's bleeding or not after preserving the cystic artery
Measured: one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start12 Aug 2025
- Primary completion14 Feb 2026
- Study completion1 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Calculous CholecystitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Suez University
- Sponsor type
- University, hospital or other
- Collaborators
- South Valley University, Queft teaching hospital
- Responsible party
- Principal investigator, Ahmad Ali Maklad, Suez University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07339501
- Sponsor's protocol ID
- SVU MED SUR011
- Status last verified
- Jun 2026
- First submitted
- 17 Nov 2025
- Last updated
- 2 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cystic Artery Preservation : an Additional Step for Safe Laparoscopic Cholecystectomy
- ClinicalTrials.gov ID
- NCT07339501
- Acronym / sponsor ID
- SVU MED SUR011
- Conditions
- Chronic Calculous Cholecystitis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Suez UniversityUniversity, hospital or other
- Collaborators
- South Valley University, Queft teaching hospital
- Study start
- 12 Aug 2025 (actual)
- Primary completion
- 14 Feb 2026 (actual)
- Study completion
- 1 May 2026 (actual)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our aim is to feature additional steps for safe cholecystectomy by preserving the cystic artery.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| group (A) | Active comparator | Procedure: The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a |
| group B | Placebo comparator | Procedure: The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- 1-Patients with symptomatic gall bladder stones. 2-Patients with normal coagulation profile.
Key exclusion criteria (1 listed)
- 1- Patients with hepatic co-morbidity especially (cirrhosis). 2-Patients with previous upper abdominal surgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery aThe patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery for save cholecystectomy | Procedure or surgery | group (A) |
| The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic arteryThe patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery | Procedure or surgery | group B |
Primary outcome
Patients will be followed up by Abdominal ultrasound for post operative abdominal collection
Time frame: one month
Follow up with ultrasound to evaluate if there's bleeding or not after preserving the cystic artery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jul 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Chronic Calculous Cholecystitis
Enrolling by invitationObservational study
Shortwave Infrared Surgical Imaging Device Study
Cholecystitis, Cholecystitis, Chronic
Not yet recruiting
Probiotic Yogurt in Patients With Chronic Cholecystitis
Chronic Cholecystitis
RecruitingPhase 1
Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers
Chronic Cholecystitis, Biliary Dyskinesia
RecruitingPhase 3
Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia
Chronic Cholecystitis, Biliary Dyskinesia
RecruitingPhase 2
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
Chronic Cholecystitis, Biliary Dyskinesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a and The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery in people with Chronic Calculous Cholecystitis, run by Suez University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patients will be followed up by Abdominal ultrasound for post operative abdominal collection (time frame: one month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.